Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Abstract Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. C...

Full description

Bibliographic Details
Main Authors: Kaipeng Xie, Chenyang Fu, Suli Wang, Hanzi Xu, Siyu Liu, Yang Shao, Zhen Gong, Xiaoli Wu, Bo Xu, Jing Han, Juan Xu, Pengfei Xu, Xuemei Jia, Jiangping Wu
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Journal of Ovarian Research
Subjects:
Cancer-testis antigens
Ovarian cancer
Tumor development
Immunotherapy
Online Access:http://link.springer.com/article/10.1186/s13048-018-0475-z

Internet

http://link.springer.com/article/10.1186/s13048-018-0475-z

Similar Items